ZNTL — ZENTALIS PHARMACEUTICALS INC

Ownership history in PFIZER INC  ·  5 quarters on record

This page tracks every 13F SEC filing in which PFIZER INC reported a position in ZENTALIS PHARMACEUTICALS INC (ZNTL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.54% (2025 Q4)
Avg. % of fund
0.3%
First filed
2024 Q4
Last filed
2025 Q4
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 953,834 — 0% 0.54% $1.3M $1.35
2025 Q3 UNCHANGED 953,834 — 0% 0.33% $1.4M $1.51
2025 Q2 UNCHANGED 953,834 — 0% 0.19% $1.1M $1.16
2025 Q1 UNCHANGED 953,834 — 0% 0.30% $1.52B $1.59
2024 Q4 INITIATED 953,834 — — 0.11% $2.89B $3.03
% of Fund (quarterly)    ZNTL price (monthly, adj. close)

Other funds also holding ZNTL

As of 2025 Q4 — sorted by position size

5AM Venture Management, LLC 3Y 1.68% Stonepine Capital Management, LLC 3Y 7Y 0.46% Opaleye Management Inc. 3Y 7Y 0.25% Decheng Capital LLC 0.24% Almitas Capital LLC 3Y 7Y 0.18% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.14% Anfield Capital Management, LLC 3Y 0.1% Quarry LP 3Y 0.03% XTX Topco Ltd 3Y 0.02% Regency Capital Management Inc.\DE 3Y 0.02%
← Back to PFIZER INC Holdings